- Home
- ASST vs STAA Comparison
ASST vs STAA Comparison
Compare ASST & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASST | STAA |
|---|---|---|
| Founded | 2020 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.7M | 867.9M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | ASST | STAA |
|---|---|---|
| Price | $8.23 | $20.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 10 |
| Target Price | ★ $30.00 | $23.36 |
| AVG Volume (30 Days) | ★ 41.2M | 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $313,901,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.44 | $14.69 |
| 52 Week High | $13.40 | $30.81 |
Technical Indicators
Market Signals| Indicator | ASST | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 64.07 | 60.69 |
| Support Level | $3.99 | $19.82 |
| Resistance Level | $12.75 | $27.80 |
| Average True Range (ATR) | 0.96 | 0.85 |
| MACD | -0.06 | 0.57 |
| Stochastic Oscillator | 21.70 | 94.70 |
Price Performance
Historical ComparisonAbout ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.